Literature DB >> 15135463

Blood transfusion risks in the intensive care unit.

Mercy Kuriyan1, Jeffrey L Carson.   

Abstract

This article reviews transfusion risks with particular emphasis on the critically ill. It describes the various types of noninfectious,infectious, and mild-to-severe reactions that can occur in a trans-fused patient. The article describes differential diagnosis of these reactions and the handling and treatment of the patient. Diagnosis of the type of transfusion reaction by laboratory tests is detailed. Finally, the article discusses the dangers of human error with possible strategies to combat this problem using new technologies.

Entities:  

Mesh:

Year:  2004        PMID: 15135463     DOI: 10.1016/j.ccc.2003.12.001

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  7 in total

1.  Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.

Authors:  Naoya Uchida; Juan J Haro-Mora; Atsushi Fujita; Duck-Yeon Lee; Thomas Winkler; Matthew M Hsieh; John F Tisdale
Journal:  Stem Cells       Date:  2016-10-26       Impact factor: 6.277

2.  Acute Transfusion Reactions (ATRs) in Intensive Care Unit (ICU): A Retrospective Study.

Authors:  Rajesh Kumar; Manvi Gupta; Varun Gupta; Amarjit Kaur; Sonia Gupta
Journal:  J Clin Diagn Res       Date:  2014-02-03

3.  Percutaneous interventions in the coagulopathic patient.

Authors:  Barbara A Konkle
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

4.  Treatment of critically ill children with kidney injury by sustained low-efficiency daily diafiltration.

Authors:  Chia-Ying Lee; Huang-Chieh Yeh; Ching-Yuang Lin
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

5.  Biallelic correction of sickle cell disease-derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum-free iPS-sac/erythroid differentiation.

Authors:  Juan J Haro-Mora; Naoya Uchida; Selami Demirci; Qi Wang; Jizhong Zou; John F Tisdale
Journal:  Stem Cells Transl Med       Date:  2020-02-07       Impact factor: 6.940

6.  Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.

Authors:  Dhruva Kumar Sharma; Supratim Datta; Amlan Gupta
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

7.  Transfusion-related adverse reactions in pediatric and surgical patients at a tertiary care teaching hospital in India.

Authors:  Kunal J Ghataliya; Jigar D Kapadia; Mira K Desai; K M Mehariya; G H Rathod; Nidhi Bhatnagar; M D Gajjar
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.